CClinicalTrials.gg
CompletedNCT07692373Updated Sep 15, 2026

Groningen Meander Walking Test in Older Adults With Balance Problems

An observational study in Fall, Gait Disorders in Old Age and Older People, sponsored by Ordu University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-09-15.

Sponsored by Ordu University · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
71
Ages
65 Years and older
Sex
All
01

Study summary

This observational cross-sectional psychometric study aims to examine the test-retest reliability and construct validity of the Groningen Meander Walking Test in older adults with self-reported balance problems and/or a history of falls. Participants aged 65 years or older will be recruited from the Orthopedics and Traumatology outpatient clinic of Ordu University Training and Research Hospital. The Groningen Meander Walking Test will be performed twice during the first session and repeated in a second session to assess within-day and between-day reliability. Construct validity will be evaluated using the Timed Up and Go Test, Figure-of-Eight Walking Test, Berg Balance Scale, and Falls Efficacy Scale-International. The study will also explore the ability of the Groningen Meander Walking Test to discriminate between participants with low and increased fall risk according to the Berg Balance Scale.

Read the detailed description

This observational cross-sectional study will evaluate the reliability and validity of the Groningen Meander Walking Test in older adults with self-reported balance problems and/or a history of falls. Participants aged 65 years or older will be recruited from the Orthopedics and Traumatology outpatient clinic of Ordu University Training and Research Hospital.

The Groningen Meander Walking Test will be administered in two assessment sessions to examine within-day and between-day test-retest reliability. Completion time and overstep score will be recorded. Construct validity will be assessed by comparing Groningen Meander Walking Test outcomes with established clinical measures of functional mobility, curved walking performance, balance, and concern about falling.

The study aims to determine whether the Groningen Meander Walking Test is a clinically useful assessment tool for advanced walking ability in older adults with balance problems and/or fall history.

02

Conditions studied

  • Fall
  • Gait Disorders in Old Age
  • Older People
03

In context

Lead sponsor

Ordu University is the lead sponsor of 31 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults aged 65 years or older with self-reported balance problems and/or a history of falls within the previous 12 months will be recruited from the Orthopedics and Traumatology outpatient clinic of Ordu University Training and Research Hospital. Eligible participants will be individuals who can walk independently with or without a single walking aid and who are able to complete the clinical walking and balance assessments.

Inclusion criteria

Aged 65 years or older Self-reported balance problems during activities of daily living and/or a history of at least one fall within the previous 12 months Able to walk independently with or without a single walking aid Able to understand and follow verbal instructions Willing to provide written informed consent

Exclusion criteria

Exclusion Criteria:

Presence of neurological, vestibular, visual, orthopedic, systemic, or medical conditions that may substantially affect gait or balance Acute lower-extremity injury or recent lower-extremity surgery Severe pain preventing completion of the walking or balance tests Cognitive impairment that may limit the ability to understand or follow test instructions Inability to walk independently without personal assistance Use of a rollator

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
71 participants (actual)
Patient registry
No

Groups and cohorts

  • Older Adults With Balance Problems

    Participants aged 65 years or older with self-reported balance problems and/or a history of falls within the previous 12 months will undergo clinical assessments, including the Groningen Meander Walking Test, Timed Up and Go Test, Figure-of-Eight Walking Test, Berg Balance Scale, and Falls Efficacy Scale-International. No intervention will be administered.

06

What researchers measure

Primary outcomes

  1. Groningen Meander Walking Test Completion Time

    Completion time of the Groningen Meander Walking Test will be recorded in seconds. The mean of the start-to-end and end-to-start completion times will be used as the Groningen Meander Walking Test completion time. A longer completion time indicates poorer advanced walking performance.

    Time frame: Baseline and 3 to 7 days after baseline

Secondary outcomes

  1. Groningen Meander Walking Test Overstep Score

    The number of times the participant's foot completely lands outside the marked pathway will be recorded. Oversteps from the start-to-end and end-to-start directions will be summed. A higher score indicates poorer stepping accuracy.

    Time frame: Baseline and 3 to 7 days after baseline

  2. Timed Up and Go Test Completion Time

    Functional mobility will be assessed using the Timed Up and Go Test. The time required to stand from a chair, walk 3 meters, turn, return to the chair, and sit down will be recorded in seconds. A longer time indicates poorer functional mobility.

    Time frame: Baseline

  3. Figure-of-Eight Walking Test Completion Time

    Curved walking performance will be assessed using the Figure-of-Eight Walking Test. Completion time will be recorded in seconds, and a longer time indicates poorer advanced walking performance.

    Time frame: Baseline

  4. Berg Balance Scale Score

    Functional balance will be assessed using the Berg Balance Scale. Total scores range from 0 to 56, with higher scores indicating better balance performance and lower fall risk.

    Time frame: Baseline

  5. Falls Efficacy Scale-International Score

    Concern about falling during daily activities will be assessed using the Falls Efficacy Scale-International. Total scores range from 16 to 64, with higher scores indicating greater concern about falling.

    Time frame: Baseline

07

Study locations

1 site
  • Ordu university
    Altinordu, Ordu 52200, Turkey (Türkiye)
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07692373
Lead sponsor
Ordu University
Responsible party
Elif AYGUN POLAT (Assistant Professor, Ordu University) — Principal investigator
First posted
Jul 9, 2026
Start date
Jul 15, 2026
Primary completion
Aug 30, 2026
Completion
Sep 7, 2026
Last update
Sep 15, 2026

Study contacts

ELİF A POLAT, Assoc.Prof.
principal investigator · Ordu University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion